CANNAPHARMARX, INC. Amortization of Debt Issuance Costs and Discounts
CANNAPHARMARX, INC. (CPMD) reported Amortization of Debt Issuance Costs and Discounts of $0 for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-06-25.
Discontinued › Cash Flow › Operating Activities
us-gaap:AmortizationOfFinancingCostsAndDiscounts · last filed 2024-06-25
- CANNAPHARMARX, INC. amortization of debt issuance costs and discounts for the quarter ending 2024-03-31 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. amortization of debt issuance costs and discounts for the quarter ending 2023-06-30 was $0.00, a 100.00% decline year-over-year.
- CANNAPHARMARX, INC. amortization of debt issuance costs and discounts for the quarter ending 2023-03-31 was $162.39K, a 60.83% increase year-over-year.
- CANNAPHARMARX, INC. amortization of debt issuance costs and discounts for the quarter ending 2022-12-31 was $95.12K, a 68.44% decline year-over-year.
- CANNAPHARMARX, INC. amortization of debt issuance costs and discounts for fiscal 2022 was $478.66K, a 61.87% decline from fiscal 2021.
- CANNAPHARMARX, INC. amortization of debt issuance costs and discounts for fiscal 2021 was $1.26M.
| Period end | Amortization of Debt Issuance Costs and Discounts 3 month | Amortization of Debt Issuance Costs and Discounts 6 month | Amortization of Debt Issuance Costs and Discounts 9 month | Amortization of Debt Issuance Costs and Discounts 12 month |
|---|---|---|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-06-25 | |||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-13 | $162.39K 10-Q · filed 2023-10-13 | $257.51K derived: sum of 3 quarters · filed 2024-06-25 | $424.10K derived: sum of 4 quarters · filed 2024-06-25 |
| 2023-03-31 | $162.39K 10-Q · filed 2024-06-25 | $257.51K derived: sum of 2 quarters · filed 2024-06-25 | $424.10K derived: sum of 3 quarters · filed 2024-06-25 | $540.08K derived: sum of 4 quarters · filed 2024-06-25 |
| 2022-12-31 | $95.12K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-01 | $261.71K derived: sum of 2 quarters · filed 2023-09-01 | $377.69K derived: sum of 3 quarters · filed 2023-10-13 | $478.66K 10-K · filed 2023-09-01 |
| 2022-09-30 | $166.59K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $282.57K derived: sum of 2 quarters · filed 2023-10-13 | $383.54K 10-Q · filed 2022-11-21 | $684.89K derived: sum of 4 quarters · filed 2023-10-13 |
| 2022-06-30 | $115.98K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-10-13 | $216.95K 10-Q · filed 2023-10-13 | $518.29K derived: sum of 3 quarters · filed 2023-10-13 | $736.37K derived: sum of 4 quarters · filed 2023-10-13 |
| 2022-03-31 | $100.97K 10-Q · filed 2023-09-22 | $402.31K derived: sum of 2 quarters · filed 2023-09-22 | $620.39K derived: sum of 3 quarters · filed 2023-09-22 | $1.07M derived: sum of 4 quarters · filed 2023-09-22 |
| 2021-12-31 | $301.34K derived: 10-K 12 month − 10-Q 9 month · filed 2023-09-01 | $519.42K derived: sum of 2 quarters · filed 2023-09-01 | $967.82K derived: sum of 3 quarters · filed 2023-09-01 | $1.26M 10-K · filed 2023-09-01 |
| 2021-09-30 | $218.07K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-21 | $666.48K derived: sum of 2 quarters · filed 2022-11-21 | $954.02K 10-Q · filed 2022-11-21 | |
| 2021-06-30 | $448.40K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-22 | $735.95K 10-Q · filed 2022-08-22 | ||
| 2021-03-31 | $287.54K 10-Q · filed 2022-05-23 |